Astrotech - ASTC Stock Forecast, Price & News

Astrotech's stock was trading at $20.40 at the start of the year. Since then, ASTC stock has decreased by 49.0% and is now trading at $10.41.
View the best growth stocks for 2022 here.

Astrotech saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 116,500 shares, an increase of 82.3% from the October 31st total of 63,900 shares. Based on an average trading volume of 314,200 shares, the short-interest ratio is currently 0.4 days. Currently, 0.3% of the company's stock are sold short.
View Astrotech's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, February 10th 2023.
View our ASTC earnings forecast.

Astrotech Co. (NASDAQ:ASTC) released its quarterly earnings results on Wednesday, September, 14th. The aerospace company reported ($1.20) earnings per share (EPS) for the quarter. The aerospace company earned $0.02 million during the quarter. Astrotech had a negative net margin of 1,226.53% and a negative trailing twelve-month return on equity of 16.29%.

Astrotech's stock reverse split on Monday, December 5th 2022. The 1-30 reverse split was announced on Monday, December 5th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 5th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

3 employees have rated Astrotech Chief Executive Officer Thomas B. Pickens III on Glassdoor.com. Thomas B. Pickens III has an approval rating of 32% among the company's employees. This puts Thomas B. Pickens III in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 55.0% of employees surveyed would recommend working at Astrotech to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Astrotech investors own include Advanced Micro Devices (AMD), Inovio Pharmaceuticals (INO), Gevo (GEVO), Voyager Therapeutics (VYGR), Allena Pharmaceuticals (ALNA), Athersys (ATHX), AzurRx BioPharma (AZRX), DURECT (DRRX) and Dynatronics (DYNT).

Astrotech trades on the NASDAQ under the ticker symbol "ASTC."

Astrotech's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.99%), Marquette Asset Management LLC (0.83%) and Renaissance Technologies LLC (0.31%). Insiders that own company stock include Braden Michael Leonard and Jaime Hinojosa.
View institutional ownership trends.

Shares of ASTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ASTC stock can currently be purchased for approximately $10.41.

Astrotech (NASDAQ:ASTC) has a market capitalization of $17.59 million and generates $870,000.00 in revenue each year. The aerospace company earns $-8,330,000.00 in net income (profit) each year or ($5.4054) on an earnings per share basis.

Astrotech's mailing address is 201 W. 5TH STREET SUITE 1275, AUSTIN TX, 78701. The official website for the company is www.astrotechcorp.com. The aerospace company can be reached via phone at (512) 485-9530, via email at ir@astrotechcorp.com, or via fax at 512-485-9531.